Viewing data from:

CEFDINIR

ANDA

CEFDINIR | A210534 | ALKEM LABORATORIES LTD

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 4 NDCs

Highest NADAC/Unit

$0.1195

per ml

Lowest NADAC/Unit

$0.1063

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
67877054898CEFDINIR 250 MG/5 ML SUSP	$0.1195	ML	Generic	—	2026-08-19
67877054888CEFDINIR 250 MG/5 ML SUSP	$0.1135	ML	Generic	—	2026-08-19
67877054798CEFDINIR 125 MG/5 ML SUSP	$0.1133	ML	Generic	—	2026-08-19
67877054788CEFDINIR 125 MG/5 ML SUSP	$0.1063	ML	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain10 active DMFs2 inactive

8 active API suppliers hold Drug Master Files for this ingredient.

LUPIN LTDCEFDINIR MONOHYDRATE USP

DMF 177052004

OLON SPACEFDINIR HYDRATE

DMF 179862004

SANDOZ GMBHCEFDINIR

DMF 184572005

ORCHID PHARMA LTDCEFDINIR FORM-B

DMF 194012006

APITORIA PHARMA PRIVATE LTDCEFDINIR USP (CRYSTAL B)

DMF 196072006

NECTAR LIFESCIENCES LTDCEFDINIR USP

DMF 255702011

COVALENT LABORATORIES PRIVATE LTDCEFDINIR USP

DMF 258822012

TIANJIN PHARMACEUTICAL HOLDINGS GENCOM PHARMACY CO LTDCEFDINIR USP

DMF 291192015

COVALENT LABORATORIES PRIVATE LTDCEFDINIR HYDRATE USP

DMF 303202016

APITORIA PHARMA PRIVATE LTDCEFDINIR USP (ANHYDROUS)

DMF 395402024

RANBAXY LABORATORIES LTDInactiveCEFDINIR

DMF 198662006

TEVA PHARMACEUTICAL INDUSTRIES LTDInactiveCEFDINIR HYDRATE

DMF 207302007

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 125MG/5ML

0 patents0 exclusivities▴

FOR SUSPENSION;ORAL | Approved: Feb 19, 2021

No patent or exclusivity listings for this strength.

#002 — 250MG/5ML

0 patents0 exclusivities▾

FOR SUSPENSION;ORAL | Approved: Feb 19, 2021